Fluzone Preservative-free
Company: Aventis Pasteur
Approval Status: Approved September 2002
Treatment for: Influenza immunization in infants
Areas: Immunology/Infectious Diseases; Pediatrics/Neonatology
| General Information | Additional Information |
General Information
Other Useful Resources
The preservative-free formulation of the Fluzone Influenza Virus Vaccine was approved in September 2002 to immunize high-risk and normal infants, aged six months to 35 months.
Fluzone is also available in its non-preservative-free formulation for pediatric and adult patients.
Additional Information
For further information about Fluzone, visit the Aventis Pasteur vaccine product web site at www.vaccineshoppe.com.
The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
